These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease? Klein WL J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404 [TBL] [Abstract][Full Text] [Related]
3. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease. Drolle E; Hane F; Lee B; Leonenko Z Drug Metab Rev; 2014 May; 46(2):207-23. PubMed ID: 24495298 [TBL] [Abstract][Full Text] [Related]
4. Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes. Canale C; Seghezza S; Vilasi S; Carrotta R; Bulone D; Diaspro A; San Biagio PL; Dante S Biophys Chem; 2013 Dec; 182():23-9. PubMed ID: 23998637 [TBL] [Abstract][Full Text] [Related]
5. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease? Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267 [TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers. Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339 [TBL] [Abstract][Full Text] [Related]
7. Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation. Wang Y; Xia Z; Xu JR; Wang YX; Hou LN; Qiu Y; Chen HZ Neuropharmacology; 2012 Feb; 62(2):871-81. PubMed ID: 21958557 [TBL] [Abstract][Full Text] [Related]
8. [Involvement of beta-amyloid in the etiology of Alzheimer's disease]. Tomiyama T Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873 [TBL] [Abstract][Full Text] [Related]
9. The role of amyloid β in the pathogenesis of Alzheimer's disease. Gilbert BJ J Clin Pathol; 2013 May; 66(5):362-6. PubMed ID: 23526599 [TBL] [Abstract][Full Text] [Related]
10. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity. Smith LM; Strittmatter SM Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 27940601 [TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
12. A strategy for designing a peptide probe for detection of β-amyloid oligomers. Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399 [TBL] [Abstract][Full Text] [Related]
14. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size. Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611 [TBL] [Abstract][Full Text] [Related]
15. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures. Thapa A; Woo ER; Chi EY; Sharoar MG; Jin HG; Shin SY; Park IS Biochemistry; 2011 Apr; 50(13):2445-55. PubMed ID: 21322641 [TBL] [Abstract][Full Text] [Related]
16. Rationally Designed Antibodies as Research Tools to Study the Structure-Toxicity Relationship of Amyloid-β Oligomers. Limbocker R; Mannini B; Cataldi R; Chhangur S; Wright AK; Kreiser RP; Albright JA; Chia S; Habchi J; Sormanni P; Kumita JR; Ruggeri FS; Dobson CM; Chiti F; Aprile FA; Vendruscolo M Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630615 [TBL] [Abstract][Full Text] [Related]
17. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity. Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832 [TBL] [Abstract][Full Text] [Related]
18. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease. Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease. Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778 [TBL] [Abstract][Full Text] [Related]
20. Low-n oligomers as therapeutic targets of Alzheimer's disease. Ono K; Yamada M J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]